A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer.

MLA

Wu, Jie, et al. “A Feature-Based Analysis Identifies COL1A2 as a Regulator in Pancreatic Cancer.” Journal of Enzyme Inhibition & Medicinal Chemistry, vol. 34, no. 1, Dec. 2019, pp. 420–28. EBSCOhost, https://doi.org/10.1080/14756366.2018.1484734.

APA

Wu, J., Liu, J., Wei, X., Yu, Q., Niu, X., Tang, S., & Song, L. (2019). A feature-based analysis identifies COL1A2 as a regulator in pancreatic cancer. Journal of Enzyme Inhibition & Medicinal Chemistry, 34(1), 420–428. https://doi.org/10.1080/14756366.2018.1484734

Chicago

Wu, Jie, Jing Liu, XiaoQing Wei, Qi Yu, XiangHuan Niu, ShuHong Tang, and Lei Song. 2019. “A Feature-Based Analysis Identifies COL1A2 as a Regulator in Pancreatic Cancer.” Journal of Enzyme Inhibition & Medicinal Chemistry 34 (1): 420–28. doi:10.1080/14756366.2018.1484734.